Number of shares outstanding for Avidity Biosciences (RNA)

Number of shares outstanding as of November 2024 : 106,928,000

According to Avidity Biosciences's latest financial reports and stock price the company's current number of shares outstanding is 106,928,000. At the end of 2024 the company had 106,928,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Avidity Biosciences from 2019 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.10 B	44.31%
2023	74.09 M	29.32%
2022	57.29 M	142.7%
2021	23.6 M	-36.97%
2020	37.45 M	81.1%
2019	20.68 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
PTC Therapeutics PTCT	76,725,070	-28.25%	🇺🇸 USA
Acorda Therapeutics ACOR	1,242,000	-98.84%	🇺🇸 USA
Sarepta Therapeutics SRPT	94,618,000	-11.51%	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	118,180,396	10.52%	🇺🇸 USA
Fate Therapeutics FATE	117,468,124	9.86%	🇺🇸 USA
Acceleron Pharma XLRN	53,824,600	-49.66%	🇺🇸 USA
Pfizer PFE	5,666,000,000	5,198.89%	🇺🇸 USA
GlaxoSmithKline GSK	2,040,000,000	1,807.83%	🇬🇧 UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions